Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program. J of Skin 2025, 9 (4), s583. https://doi.org/10.25251/ed52rz19.